Natural Hormones in Food-Producing Animals:Legal Measurements and Analytical Implications by Patricia Regal et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
12 
Natural Hormones in Food-Producing  
Animals: Legal Measurements 
 and Analytical Implications 
Patricia Regal, Alberto Cepeda and Cristina A. Fente 
University of Santiago de Compostela, 
 Spain 
1. Introduction  
Hormones are chemicals that are naturally produced in the body of animals and human beings 
and have a number of important functions in life, such as reproduction or growth. They act as 
messengers through the different parts of the organism and trigger and modulate key 
reactions to support and promote life. However, and due to the important role of these 
chemicals in several body functions, they also have been exogenously applied to animals and 
humans in order to obtain some kind of benefit in health or even to improve physical and 
growth performance. Focusing on the veterinary field, the most desirable action of hormones 
has always been reducing costs and obtaining more products of animal origin in shorter 
productive times, increasing the benefit per unit head for farmers. As a matter of fact, anabolic 
steroid hormones have played a key role among veterinary products in farming history and 
they have been one the most used and controversial components among veterinary drugs.  
Usually, hormones work in harmony in the body and this status must be maintained to avoid 
metabolic disequilibrium and the subsequent illness. Besides, it has been reported the 
influence of exogenous steroids (presence in the environment and food products) in the 
development of several important illness in humans. With regard to food safety when treating 
animals with exogenous hormones, consumers’ concerns have led to a complete prohibition of 
the use of substances having a hormonal action in food producing animals in the EU. Even 
when several regulations and laws exist all over the world with regard to the use of natural 
and synthetic hormones in animal husbandry, natural hormones have arisen as a real weak 
point of residue monitoring plans due to their natural origin. The existence of high variability 
through animals in terms of natural hormonal levels has been reported. This latest fact makes 
almost impossible to establish legal thresholds to control any exogenous administration of 
natural hormones to animals. That is why no final legal solution has been found yet to control 
the misuse and abuse of natural hormones exogenously applied to farm animals, even though 
a number of promising analytical procedures have already been published.  
2. Anabolic steroid hormones 
Throughout history, a large number of natural and synthetic substances have been applied 
in stock farming to speed up and improve animal growth, and to decrease feed costs. 
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Anabolic agents or growth promoters are metabolic modifiers which improve efficiency and 
profitability of livestock production and improve carcass composition (Dikeman, 2007). 
Main physiologic effects of anabolic steroids include growth of muscle mass and strength, 
increased bone density, maturation of the sex organs, particularly important in the fetus, 
and at puberty the appearance of the secondary sex characteristics. The group of anabolic 
growth promotants includes compounds that naturally occur in an animal’s body and 
synthetic chemicals that mimic the action of naturally occurring compounds. Meat industry 
have widely used anabolic hormones to quickly get larger quantities of meat and decrease 
inputs, reducing production costs, but also because they lead to a leaner carcass more in 
accordance to current consumer’s preferences. Additionally, the zootechnical use of some 
sex hormones, such as estradiol or its esters (i.e., estradiol benzoate), which successfully 
regulate oestrus in cattle, has also led to important improvements and financial gain in stock 
farming (Cavalieri et al., 2005; Martínez et al., 2002). 
Several illegal hormones have been used in the European Union (EU), as it has been 
reported in a series of European International Symposia and Conferences, such as 
EuroResidue Conferences on Residues of Veterinary Drugs in Food (Federation of European 
Chemical Societies, Division of Food Chemistry) and the Ghent Symposia on Hormone and 
Veterinary Drug Residue Analysis, amongst others. The number of active compounds is 
wide and continuously changing, as observed by the EU National Reference Laboratories 
(NRLs). Estrogenic, gestagenic and androgenic compounds (EGAs), as well as thyreostatic, 
corticosterois and ǃ-agonist compounds, are also used alone or in growth promoting 
“cocktails” with low concentrations of several ones, that makes even more difficult their 
detection. There have been several European regulations regarding the use of EGAs as 
animal growth promoters because of their possible toxic effect on public health. In the 
Council Directive 96/22/EC (EC, 1996a) the EU prohibited the administration of substances 
having thyreostatic, oestrogenic, androgenic or gestagenic effects and of beta agonists in 
animal husbandry, while certain therapeutic applications of these drugs were still allowed. 
These anabolic steroids are included in group A substances according to Annex I of 
Directive 96/23/EC (EC, 1996b), which pertains to growth-promoting agents abused in 
animal fattening and unauthorized substances with no maximum residue limit (MRL). A 
zero-tolerance policy has been adopted, and especial analytical requirements have been 
stated in regard to these hormones (EC, 2002; European Commission, Directorate General 
for Health & Consumers, 2004). However, the possibility of widespread abuse of hormonal 
substances by unscrupulous farmers and veterinary professionals in some parts of Europe 
still exists, mainly due to the economic benefits these substances provide in animal 
husbandry. On the other hand, the use of hormones to promote growth is still a legal 
practice in some parts of the world, which facilitates the existence of a possible “black 
market” of substances from these areas. 
2.1 Estrogenic drugs 
Cattle are the main food-producing species in which estradiol products are used for therapy 
or growth promotion. Estradiol benzoate, one of the most applied steroids in animal 
husbandry, was authorized for the treatment of pyometra and endometritis, for dilation of 
the cervix in cases of abortion, to enhance the expression of estrous behaviour, and to 
provoke luteolysis incorporated into estrous synchronization drug devices (i.e. PRID, 
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CIDR), among other applications (Levy, 2010). In meat industry, it has been already 
reported that estrogenic implants (alone or in combination) increase carcass weight and 
longissimus muscle area and decrease intramuscular fat, compared with non-implanted 
steers (Boles et al., 2009; McPhee et al., 2006; Parr et al., 2011). Estrogenic implants also 
decrease kidney, pelvic and heart fat but apparently this fat increases for combination 
implants (McPhee et al., 2006). Cattle repeatedly treated with estradiol and trenbolone 
acetate implants have greater average daily gain and final weights than single-treated or 
non-treated steers, as well as more mature skeletons and higher protein content in their 
carcasses (Scheffler et al., 2003). However, hormonal treatments may have a negative effect 
on tenderness and meat quality of beef because they reduce marbling and advance skeletal 
or lean maturity (Dikeman, 2007; Hunter, 2010; Scheffler et al., 2003), this effect being more 
pronounced with combination implants than with estradiol alone. Beef flavour, juiciness 
and tenderness might be affected by trenbolone acetate implants but apparently this effect 
decreases with aging time (Igo et al., 2011).  
On the other hand, the economic profitability of a dairy farm is based on the calving interval of 
the cows, in order to keep them as long as possible into lactating phase. To achieve this, the 
cow needs to get pregnant very quickly during postpartum, so the main step is the 
determination of the optimal time for insemination, basing on estrous behaviour. The 
expression of estrous behaviour is at a low level in modern dairy cows, resulting in low 
detection rates and longer calving intervals (Senger, 1994). Estradiol-based drugs, particularly 
those combined with progestins, appeared as a really effective and efficient solution to estrus 
detection problems in farm animals, allowing artificial insemination synchronization and high 
pregnancy rates to fixed-time artificial insemination in dairy cows, sheep and other farm 
animals (Burkea et al., 2001; Martínez et al., 2002). Although Directive 2003/74/EC, amending 
Directive 96/22/EC, permanently prohibited the use of estradiol-17ǃ and its ester-like 
derivatives as growth promoters, a temporary exemption was given until 14 October 2006 for 
their use as an oestrous-induction tool in cows, horses, sheep or goats (EC, 2003). As 
alternative effective products exist and are implemented in the market (Lane et al., 2008; 
Vilariño et al., 2010), the European Parliament banned estradiol-17ǃ and its ester-like 
derivatives, including those with a therapeutic purpose, in 2008 to ensure human health 
protection within the EU (EC, 2008). In the absence of estradiol-based products, alternatives for 
estrous synchronization are prostaglandin or the progesterone-releasing devices. Alternatives 
for the treatment of pyometra and endometritis could include the use of prostaglandins thanks 
to a combination of their direct ecbolic and luteolytic effects. 
No estradiol-based drugs are in the European veterinary market anymore, except for its use 
in pets (EC, 2008). However, the possibility of widespread abuse of hormonal substances by 
unscrupulous farmers and veterinary professionals in some parts of Europe still exists, 
mainly due to the economic benefits that these substances provide in animal husbandry and 
the existence of authorized drugs in other non-European countries (Stephany, 2001). Limited 
research was found on the effects of anabolic implants in poultry, sheep, and pigs. Anabolic 
steroids are not approved for growth regulation in pigs in the United States (US) and 
numerous other countries. Even so, Lee et al., 2002 and Sheridan et al. 1999 studied the effect 
of anabolic steroids in pigs, concluding that they were not suitable agents to improve 
growth or carcass characteristics of pigs, but mid-back fat appeared reduced anyway (Lee et 
al., 2002; Sheridan et al., 1990). 
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2.2 Androgenic and gestagenic drugs 
Androgenic and gestagenic growth promotants approved in the US include steroid 
hormone anabolic implants with testosterone, progesterone, trenbolone and melengestrol 
acetate, all of them banned in EU. With the exception of melengestrol acetate, the 
recommended administration of these drugs is by subcutaneous implantation of 
continuously releasing hormone pellets in the ear. Androgenic hormones (testosterone and 
trenbolone acetate) directly reduce fat content of the carcass (Hunter, 2010) and have proved 
to be also effective in chicken to increase muscle quality and quantity (Chen et al., 2010). 
Medroxyprogesterone, chlormadinone, megestrol and melengestrol are synthetic analogues 
of progesterone that are commonly administered orally as acetate derivatives. They are used 
for synchronization of estrous, but have also been used as growth promoters in cattle. 
Although forbidden within the EU, the misuse of these natural and synthetic hormones is 
well known. For this illegal purpose they are frequently injected into the animal body as 
‘hormone cocktails’ including new compounds each day, such as gestagens delmadinone 
acetate and algestone acetophenide (Daeseleire et al., 1994). 
3. Human health and hormones 
Endogenously synthesized steroid hormones exert a wide range of biological effects on the 
body and not only in the reproductive organs, which is why they are vital in normal 
development and life. Possible effects vary according to a number of factors such as gender 
and age, ethnicity and even environment. However, exogenous steroidogenically active 
compounds may interfere in the hormonal endogenous equilibrium affecting health and 
natural body development. As any other chemicals of natural or synthetic nature, hormones 
can be “toxic” to living organisms under certain circumstances, due to an excessive exposure 
at an abnormal stage during development or adult life. The current increasing trends of 
cancer and reproductive disorders have been frequently related to exogenous steroids food 
intake and endocrine disrupters that are present in the environment. The major areas of 
concern expressed in the literature are related to cancer, mutagenicity and reproductive 
effects, in particular endocrine disruption. Generally, cancer and mutagenicity are well 
described and well understood but endocrine disruption has become, in recent years, an 
area where there has been concern about potential harmful outcomes for a wide range of 
chemicals previously unsuspected of causing such effects. 
As a matter of fact, the possible impact of exogenous steroid hormones, such as natural and 
synthetic hormones present in food products, are more dangerous for certain groups of 
population which are considered to be more sensitive and vulnerable than the rest. As 
regard to naturally occurring sex hormones, such as estradiol or testosterone, daily 
endogenous production and exogenous intake (in food) seem to be key points to evaluate 
risk. Taking children as reference population with the lowest levels of endogenous synthesis 
of steroids, an assessment of their plasmatic levels and of the presence of these chemicals in 
food are crucial. For this purpose, highly sensible and accurate techniques based on 
chromatography and mass spectrometry are required. Additionally, circulating levels of 
hormones have resulted to be lower than previously reported for prepubertal children and 
fetuses. First assessments of estradiol levels in serum of prepubertal boys and girls were 
based on radioimmunoassay (RIA) and its concentration appeared in most cases in a range 
of difficult accurate measurement, very close or even below conventional detection limit, 
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resulting in overestimated values (Aksglaede et al., 2006; Bay et al., 2004). Tandem mass 
spectrometry methods in combination with gas chromatography or liquid chromatography 
for sex steroid hormones have been developed and are the methods of choice for the 
accurate measurement of the low levels of testosterone found in children and females and 
even the low levels of estradiol in postmenopausal women, men and the prepubertal child 
(Kushnir et al., 2010; Moal et al., 2007; Nelson et al., 2004; Stanczyk et al., 2007). Actually, the 
current and more sensitive assays, mainly mass-spectrometry-based analysis, have revealed 
that previous RIA values were in fact overestimated and sex steroids in children are 
extremely low (Courant et al., 2010). There are no limits for hormones which assure 
children’s safety under exposure to exogenous steroids and endocrine disruptors. 
Furthermore hormonal changes or disruption during fetal life or puberty may provoke 
serious subsequent problems in their adult life. Since no safe threshold has been established 
yet, it seems necessary to avoid unnecessary children’s and fetuses’ exposure to exogenous 
disruptors, natural or synthetic, present in food even at very low levels (Bay et al., 2004). 
Both exogenous hormones and synthetic compounds mimicking their effects may change 
the endogenous balance of human body, provoking disturb in their natural functions. As a 
result of their low endogenous levels, children are extremely sensitive to exogenous steroid 
hormones and small variations in blood levels might trigger serious pubertal development 
effects and even future adult life problems (Aksglaede et al., 2006; Alves et al., 2007). Several 
epidemiological studies have proved the existence of a trend to earlier puberty in American 
girls during last decades, and incidence is on the rise. In 1997, Hermann-Giddens et al. 
reported an unexpected advance in timing of puberty in both African-American and white 
American girls (Herman-Giddens et al., 1997). An advance in timing of onset of puberty has 
not been noted yet in other countries, although it is likely to become more prevalent as other 
countries adopt American lifestyle and diets (Parent et al., 2003). Precocious puberty has 
health and social implications, it is complex and influenced by multiple factors such as 
ethnicity, gender, nutrition, endocrine disrupting chemicals, pollutants and exogenous sex 
steroids (Aksglaede et al., 2006; Cesario & Hughes, 2007; Daxenberger et al., 2001). 
However, there is a key difference between US and the rest of the world, since they still 
allow the use of some hormonal drugs in food producing animals. This fact might not be a 
bare coincidence and mean an increase on the exogenous intake of steroids for American 
children (Aksglaede et al., 2006; Partsch & Sippell, 2001). 
On the other hand, a tendency to increasing incidence of certain cancer types, such as 
testicle, breast and prostate cancer, has not been fully clarified yet, though sex hormones are 
suspected to play a key role (Foster et al., 2008; Huyghe et al., 2003; Prins, 2008; Wigle et al., 
2008). For instance lung cancer, which is the leading cause of cancer deaths in the United 
States and has surpassed breast cancer as the primary cause of cancer-related mortality in 
women, has been related to estradiol along with tobacco consumption by Meireles et al. 
(Meireles et al., 2010). Estrogens have also been linked to other types of cancer such as 
squamous cell carcinoma of the head and neck (HNSCC), which is the sixth most common 
type of cancer in the United States (Shatalova et al., 2011). Estrogen exposure is one of the 
established risk factors for breast cancer, the most commonly diagnosed cancer in women 
(Zhong et al., 2011). An association between the risk of breast cancer and persistently 
elevated blood levels of estrogen and androgen has been found in many studies (Kaaks et 
al., 2005; Yager & Davidson, 2006). Metabolites of zeranol, a non-steroidal anabolic growth 
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promoter with potent estrogenic activity and widely used in the US, contained in meat 
produced from cattle after zeranol implantation, may be a risk factor for breast cancer 
(Zhong et al., 2011). Experimental and epidemiological data support a role for sex steroid 
hormones in the pathogenesis of endometrial cancer as well. As a matter of fact, circulating 
androgen levels were also related to endometrial cancer, although less strongly than 
circulating estrogen levels (Lukanova et al., 2004). However, the effect of elevated androgen 
(androstenedione and testosterone levels) on endometrial cancer risk seems to be mediated 
mainly through their conversion to estrogens.  
As recently reported by Kvarnryd et al., progestogens exposure might have reproductive 
toxicity as well, in animals and humans, provoking defects on the development of female 
sex organs and subsequent infertility (Kvarnryd et al., 2011). The level of serum 
progesterone has not been associated with a risk of breast cancer in postmenopausal 
women, but in premenopausal women it appears to be inversely associated with the risk of 
breast cancer (Micheli et al., 2004). As for androgenic steroids, circulating concentrations of 
dehydroepiandrosterone (DHEA) and DHEA appear markedly decreased during aging, and 
thus this fact implicates the natural androgen in cognitive decline associated to age (Sorwell 
& Urbanski, 2010). On the other hand, increased blood levels of DHEA and its sulphate have 
been found in schizophrenia patients, and apparently these levels are strongly correlated to 
the severity of illness and aggressive behaviour of patients and to the pathophysiology of 
other stress-related psychiatric disorders (Garner et al., 2011; Strous et al., 2004).   
As regard to hormonal content, all foodstuff of animal origin contains steroid hormones and 
metabolites, but their concentrations vary with the kind of food, species, gender, age and 
physiological stage of the animal (Daxenberger et al., 2001; Poelmans et al., 2005a, 2005b). As a 
matter of fact, meat is clearly one of the most naturally ‘contaminated’ foods (Maume et al., 
2001; Maume et al., 2003; Poelmans et al., 2005a). Data published by Swan et al. in 2007 already 
suggested that maternal beef consumption may alter males’ testicular development in utero 
and adversely affect his adult reproductive capacity (Swan et al., 2007). Even milk 
consumption, the hormone content of which is well known, has been associated with an 
increased risk of early menarche (Wiley, 2011). There are studies that find a relationship 
between milk and dairy products with human illnesses, such as teenagers’ acne, prostate, 
breast, ovarian and corpus uteri cancers, many chronic diseases that are common in Western 
societies, as well as male reproductive disorders (Adebamowo et al., 2008; Ganmaa et al., 2011; 
Ganmaa et al., 2001; Givens et al., 2008; Melnik, 2009; Wiley, 2011). There are many possible 
contributory factors to these health problems, including steroid hormones which are well 
known as endocrine disruption agents. In this field, some studies have arisen regarding sex 
hormone levels in milk in relation to animals’ pregnancy, most of them regarding estrogens 
and androgens (Courant et al., 2007; Farlow et al., 2009; Ganmaa & Sato, 2005; Maruyama et 
al., 2010; Pape-Zambito et al., 2010). Cow’s milk contains considerable quantities of hormones 
and is therefore of particular concern (Courant et al., 2007). It is a fact that dairy milk 
consumption by humans started around 2000 years ago, but the milk which people drink 
today is quite different from traditional milk. As a result of modern farming and animal 
breeding, today’s milk originates from genetically improved dairy cows such as Holstein, 
which are pregnant during most of their lactation period (Maruyama et al., 2010).  
Regarding potential toxicological substances used in animal husbandry, for the endogenous 
sex steroids and their simple ester derivatives the US Food and Drug Administration (FDA) 
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concluded that ‘safety can be assured’ because they are endogenous in both food-producing 
animals and people. Additionally, they stated that ‘…no additional physiological effect will 
occur in individuals chronically ingesting animal tissues that contain an increase of 
endogenous sex steroids from exogenous sources equal to 1% or less of the amount in 
micrograms produced by daily synthesis in the segment of the population with the lowest 
daily production. We believe that the 1% value is supported by scientific evidence, is 
reasonable, and reflects sound public health policy. For estradiol and progesterone, 
prepubertal boys provide the baseline benchmark. For testosterone, prepubertal girls 
provide the baseline benchmark…’ (U.S. Department of Health and Human Services, 2006). 
The FDA stated that although not all sex steroids are demonstrated carcinogens, they should 
be regarded as suspect carcinogens. As a matter of fact, the FDA concluded that to establish 
the safety of a synthetic steroid animal testing is necessary. However, to show the safety of 
an endogenous sex steroid, the sponsor simply have to demonstrate that, under the 
proposed conditions of use, the concentration of residue of the endogenous steroid in 
treated food-producing animals is such that the increase will not exceed this 1% permitted 
increase. The Joint Food and Agricultural Organisation/World Health Organisation 
(FAO/WHO) Expert Committee on Food Additives (JECFA) and the US Food and Drug 
Administration (FDA) considered, in 1988, that the residues found in meat from treated 
animals were safe for the consumers. However, current recommendations might be 
overestimated and should be revised, altogether with hormonal levels in children. The lack 
of known proved hormonal thresholds, under which value no effects could be observed in 
humans, add uncertainty to this issue. 
4. Legal implications 
The use of hormonal growth promoters to increase the production of muscle meat has led to 
international disputes about the safety of meat originating from animals treated with such 
anabolics. Implants containing anabolic steroids are widely used in the US beef industry, 
among other countries, to fast growth and finish cattle and to improve feed efficiency. 
Growth promotants approved in the US include steroid hormone anabolic implants (17ǃ-
estradiol, testosterone, progesterone, trenbolone, zeranol, melengestrol acetate) and ǃ-
agonist feed additives (ractopamine) for finishing swine, cattle and turkeys, all of them 
banned in EU (U.S. FDA, 2010). With the exception of melengestrol acetate, the 
recommended administration of estradiol, progesterone, and testosterone (three natural 
hormones), and zeranol and trenbolone acetate (two synthetic hormones) is by 
subcutaneous implantation of continuously releasing hormone pellets in the ear. This ear 
would be then discarded during slaughtering but there is no withdrawal time for any of 
these legally approved implants. Melengestrol acetate is approved for its use as a feed 
additive. As a result of the existence of these legal drugs, a significant part of cattle raised in 
US feedlots are treated with growth promoting sex hormones. Over 97% of cattle weighing 
700 lbs or more received at least one anabolic implant during the finishing period in 1999 
(Salman et al., 2008). In general, a decrease on the use of growth promoting implants in US 
cattle over the past twenty years has been observed. More than one of four farms implanted 
some calves with growth promotants prior or at weaning in 1992, but fewer than one of 
eight did so in 2007 (USDA, 2009). The reason of this decline on the use of implanting, a 
profitable US management practice, could be the publicity surrounding hormonal implants 
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and movement toward marketing cattle in natural or organic programs. The most used 
substances are estrogenic drugs, in the form of estradiol-17ǃ, estradiol benzoate or the 
synthetic zeranol. Progesterone, testosterone and the two synthetic chemicals trenbolone 
acetate and melengestrol acetate are generally used in combination with estrogens. It is also 
a standard legal practice to use hormones to promote the growth of cattle in the meat 
industry in Australia (Hunter, 2010). These chemicals are approved, registered and 
regulated by the Australian Pesticides and Veterinary Medicines Authority (APVMA) 
which, as well as US Food and Drug Administration (FDA), keeps its position on saying that 
they are safe for consumers, not harmful to animals and effective when used according to 
label instructions. As a consequence, regulatory controls would differ sharply between the 
UE and the countries where hormonal active growth promoters are still legal.  
The European ban of the use of hormones arose in the 70s due to the health consequences 
derived from the use of diethylstilbestrol (DES), a synthetic estrogen widely administered to 
women to prevent miscarriage and other pregnancy complications. This chemical led to 
reproductive problems in treated women, as well as reproductive alterations, gynecologic 
cancer and malformations in reproductive organs in their female children, above normal 
average values (Auclair, 1979; Cousins et al., 1980; Haney & Hammond, 1983; Rosenfeld & 
Bronson, 1980). In 1980, European consumer organizations called for a boycott of beef as a 
result of widespread publicity involving illegal use of diethylstilbestrol in European veal 
production. In response, EC agriculture ministers agreed to ban the use of hormones for 
raising livestock with the enactment of the first legal European ban of hormones in 1981 (EEC, 
1981), with the adoption of restriction in livestock production prohibiting the use of synthetic 
hormones and substances having a hormonal activity and limiting the use of natural hormones 
to therapeutic purposes. The Directive 81/602/EEC prohibited the use of certain substances 
having hormonal action (estradiol-17ǃ, progesterone, zeranol, trenbolone acetate, melegestrol 
acetate or MGA) and thyrostatic, as growth promoters in farm animals. However, the Council 
recognized that five of the hormones at issue here (all but MGA) were of a different status than 
the other banned hormones and directed the Commission to provide a report on the 
experience acquired and scientific developments, accompanied, if necessary, by proposals 
which take these developments into account.  In the meantime, the individual Member State 
regulations would continue to apply to the use of these five hormones. 
Seven years later, the Directive 88/146/EEC was enacted, aiming at banning the 
administration of synthetic hormones (zeranol and trenbolone acetate) with any purpose, 
and natural hormones (estradiol, progesterone and testosterone) to promote growth in cattle 
(EEC, 1988a). This Directive allowed State Members to authorize the administration of those 
natural hormones, under certain circumstances, with therapeutic and zootechnical purposes. 
Both intra community trade and importation from non-European countries of meat and 
meat products from animals treated with chemicals with estrogenic, progestogenic and 
androgenic or thyrostatic effects were specifically forbidden with Directive 88/146/EEC. 
Meat from animals treated with a therapeutic or zootechnical purpose was allowed under 
certain circumstances, established with Directive 88/299/EEC (EEC, 1988b). In 1996, 
Directive 96/22/EC, a revision and repealing of previous hormone Directives, established 
the ban of substances having thyrostatic, estrogenic, androgenic and gestagenic action in 
animal husbandry and aquaculture (EC, 1996a). The Directive 96/23/EC on measures to 
monitor certain substances and residues thereof in live animals and animal products, was 
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released to establish that Member States should draft a national residue monitoring plan for 
the groups of substances detailed in its Annex I (EC, 1996b). These plans had to comply with 
the sampling rules in Annex IV to the Directive. It also established the frequencies and level 
of sampling and the groups of substances to be controlled for each food commodity. This 
Directive included the control of a wide range of veterinary drugs in food producing 
animals and goods derived from them, such as meat, eggs and honey. In Annex I, 
substances were classified in two groups: group A included substances having anabolic 
effect and unauthorized substances, and group B included authorized veterinary drugs, the 
MRL of which have been established, and contaminants. So that for residues of substances 
from group A, a ‘zero tolerance’ applied. 
In 2003, the Council Directive 2003/74/EC amended Directive 96/22/EC and narrowed 
circumstances under which estradiol-17ǃ and its ester-like derivatives could be 
administered, under strict veterinary prescription and for non-growth-promoting purposes 
(treatment of foetus maceration or mummification or treatment of pyometra in cattle, and in 
oestrus induction in cattle, horses, sheep or goats until 14 October 2006) (EC, 2003). Those 
authorized treatments had to be carried out by the veterinarian himself or herself on farm 
animals which have been clearly identified, and had to be registered by the veterinarian 
responsible. Lately, the Council Directive 2008/97/EC was enacted to take into account the 
European Protocol on protection and welfare of animals, limiting the scope of Directive 
96/22/EC only to food-producing animals and withdrawing the prohibition for pet animals, 
as well as to adjust the definition of therapeutic treatment (EC , 2008). As a matter of fact, an 
efficient control of residues is an essential contribution to the maintenance of a high level of 
consumer protection in the EU and it was necessary to provide clear rules on how 
laboratory analysis had to be carried out and results interpreted. That was achieved with 
Commission Decision 2002/657/EC, implementing Council Directive 96/23/EC, which 
established criteria and procedures for the validation of analytical methods to ensure the 
quality and comparability of analytical results generated by official laboratories (EC, 2002). 
Moreover, the Decision established common criteria for the interpretation results and 
introduced a procedure to establish minimum required performance limits (MRPL) for 
analytical methods employed to detect substances for which no permitted limit (MRL) had 
been established. This is in particular important for substances whose use is not authorized 
or is specifically prohibited in the EU, such as hormonally active substances. For the first 
time, the concepts of decision limit (CCǂ) and detection capability (CCǃ) were introduced, 
as quality parameters that must be established during the validation of an analytical 
method. Currently, the evolution in analytical equipment and progress in scientific research, 
accompanied by recent European regulatory changes, seems to demand an update or 
revision of the 2002/657/EC (Vanhaecke et al., 2011). 
Unlike in European countries, a number of steroidogenic drugs, which are used as hormonal 
growth promoters, are registered for use in many countries including Australia, New 
Zealand, United States and Canada, among others. However, the EU has been constantly 
banning their use since early 80s with Directive 81/602/EEC and neither allows the 
importation of products from cattle given growth promoters. In 1998, the World Trade 
Organization (WTO) found the European ban not supported by scientific evidence and 
inconsistent with its WTO obligations, but Europe continues arguing consumers’ concerns, 
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animal welfare and meat quality so that its rule remains in place currently. Although the 
World Trade Organization has issued decisions that have questioned the validity of the 
European ban, the EU has repeatedly voted to maintain it, citing consumer worries, 
questions of animal welfare and meat quality. 
5. Beef hormone: US versus EU and trade dispute 
Growth hormones are used extensively around the world to enhance the performance of 
beef cattle. In 1981 the European Union adopted first restrictions on the use of hormones as 
growth promoters in beef production with Directive 81/602/EEC, the first hormone 
directive (EEC, 1981). This directive prohibited the utilization of stilbenes and thyrostatics, 
two hormonal substances presumed to have harmful effects. Later in 1989 the EU fully 
implemented ban on imports of meats treated with enhancing hormones, expanding their 
restrictions to other non-European countries wishing to export meat to EU and that would 
assume many of the rights and obligations of European single market. The ban of imported 
hormone-beef arose from European consumers’ pressure more than from producers, and it 
meant great losses for the US meat industry. The EU justified the ban as needed to protect 
the health and safety of consumers from the illegal and unregulated use of hormones in 
livestock production in several European countries. During the 1980s, there were 
widespread press reports of black market sales of ‘hormone cocktails’ by a ‘hormone mafia’ 
as well as several reports of serious health effects from consuming meat from animals 
treated with enhancing hormones. Many European livestock producers support the 
hormone ban because of the possible existence of competition from cheaper imported beef 
from beef exporting countries using hormones to breed animals. Also consumers’ increasing 
demand of hormone-free meat creates concerns among European farmers about maintaining 
the ban. Certain circumstances, such as the Italian hormone crisis (Loizzo et al., 1984; Loizzo, 
1984) and the outbreak during the 1990s of bovine spongiform encephalopathy (BSE), so 
called ‘mad cow disease’, added consumer distrust about the safety of beef supply. 
Although the BSE problem had nothing to do with hormones, it also contributed further to 
an unfavourable politic-economic and social environment for resolving the beef hormone 
dispute between EU and US and Canada.  
For the past 15 years, the United States and the European Union have been disputing the 
safety of growth promotants used in cattle. The disagreement over the use of hormones 
started when the EU banned the import of beef from cattle treated with hormones in 1989, 
cutting off exports of beef. Unlike EU, the use of natural hormones in farm animals keeps 
avoiding any legal ban as the US Food and Drug Administration (FDA) says use of 
hormones is ‘safe and scientifically backed up with research’. Since the 1950s, the FDA has 
approved a number of steroid hormone drugs for use in farm animals, including estradiol, 
progesterone, testosterone, and their synthetic versions zeranol, melengestrol acetate and 
trenbolone acetate. FDA claims that people are not at risk eating food from animals treated 
with these drugs because the amount of additional hormone following drug treatment is 
very small compared with the amount of natural hormones that are normally found in the 
meat of untreated animals and that are naturally produced in the human body. 
Consequently, hormones have continued to be used to promote growth in beef cattle both 
legally in the US and elsewhere in the world and illegally within the EU.  
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In response to US threats to challenge the ban in early 1996, the European Parliament voted 
unanimously to keep it, citing consumers’ concerns, animal welfare and meat quality, 
among other reasons. European farm ministers from different EU countries also supported 
the ban, only the Minister of Agriculture of UK voted to end it arguing that there was no 
scientific basis to maintain it. The trade dispute took turn in 1996 when US presented its case 
against EU hormone ban to the World Trade Organization (WTO). The WTO, a dispute-
settlement mechanism born in 1995, found that the European ban was not based on evidence 
in 1997. However, the European Commission (EC) appealed against this statement and 
sponsored research studies to clarify the risk for consumers of hormonally active substances 
applied in food producing animals. Altogether six substances were at issue in the dispute, 
three naturally occurring hormones (estradiol-17ǃ, testosterone, and progesterone) whose 
level in animals can vary significantly, depending on age, sex, and sexual development of 
the animal, among other factors, and three synthetic substances (trenbolone, zeranol, and 
melengestrol acetate) that are produced synthetically to mimic the effect of the three 
naturally occurring hormones. The EC’s Scientific Committee on Veterinary Measures 
relating to Public Health (SCVPH) concluded that the risk from hormone-treated food was 
higher than previously thought and proposed that there was a significant body of scientific 
evidence suggesting that 17ǃ-estradiol should be considered a complete carcinogen. It also 
concluded that there were risks to consumers from the other five hormones examined and 
no threshold concentrations could be defined. The EU invoked the precautionary principle 
as a rationale for its banning the import of beef produced using hormones. The Agreement 
on Application of Sanitary and Phyto-sanitary Measures (SPS) permits precautionary 
measures when a government considers the scientific evidence insufficient to permit a final 
decision on the safety of a product, as is the case of hormonally produced food. The WTO 
Panel upheld US position and the EU was given until May 13 1999 to bring its measure into 
compliance. However, the EU Commission voted again unanimously to continue the ban. In 
maintaining its unscientific ban, the EU does nothing to further the objective of protecting 
public health, but instead undermines the WTO Sanitary and Phytosanitary Agreement 
(SPS) and invites other countries to renege on their international obligations. 
Despite the attempts of US to solve this dispute, the EU reaffirmed its position that there is a 
possible risk to human health associated with hormone-treated meat, basing on available 
scientific data. To date, the EU continues to ban import of meat from animals treated with 
hormones and only imports high-quality beef certified as produced without the use of 
hormones. However, on May 13 in 2009, following a series of negotiations, the United States 
and the EU signed in Geneva a memorandum of understanding (MOU) implementing an 
agreement that could resolve this longstanding dispute. Under MOU the EU expanded the 
market access of US beef, at zero duty, from cattle raised under control measures specified 
in USDA’s Non-Hormone Treated Cattle (NHTC) program, from cattle grown in approved 
farms/feedlots. To become eligible to export non-treated beef, producers must obtain 
certification for their cattle through the NHTC program. Meanwhile, the US and Canada 
continue retaliating against the EU hormone ban based on the additional costs of producing 
non-hormone treated beef for the European Union and the lack of evidence of its harmful 
effects in humans. Despite all the US controversy, in a survey of US consumers it was found 
that most respondents desired the existence of mandatory labelling of food produced with 
growth hormones, even when labelling costs causing beef prices increase up to 17% (Lusk & 
Fox, 2002). While the dispute is between Canada and the US and the EU, other important 
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beef-producing countries have approved the use of growth-promoting hormones in beef 
production such as Canada, New Zealand, South Africa, Mexico, Chile, and Japan, among 
others. Like for US meat, thigh controls are in place to ensure all beef exported to EU comes 
from non-hormone treated cattle. 
6. Progress on analytical methodology 
During the past few years, many authors have described the application of LC-MS/MS 
methods for the analysis of anabolic steroids in various biological samples, including urine, 
serum, hair, kidney and fat (Draisci et al., 2000; G. Kaklamanos et al., 2009a; Kaklamanos et 
al., 2009b; Kaklamanos et al., 2011; Shao et al., 2005), all validated according to the criteria 
set out in Decision 2002/657/CE for banned substances. Although normally the levels of 
steroids that accumulate in animal tissues are lower than in other matrices, many effective 
methods are known currently for the determination of these compounds in muscle tissue, 
sometimes monitoring a wide range of anabolic compounds (Courant et al., 2008; 
Kaklamanos et al., 2007; Vanhaecke et al., 2011; Yang et al., 2009). Since the number of 
growth promoters is high and includes natural and synthetic compounds, the use of 
multianalyte techniques is becoming more interesting (Vanhaecke et al., 2011; Xu et al., 2006; 
Yang et al., 2009). The use of ultra-resolution liquid chromatography techniques (UPLC), 
coupled to mass spectrometry devices, provides a rapid separation of analytes, shortening 
analytical times and improving the simultaneous detection of multiple steroids (Stolker et 
al., 2008; Vanhaecke et al., 2011). 
6.1 Synthetic and semi-synthetic steroids 
Synthetic hormones are xenobiotic substances that do not naturally occur in animal 
organisms. These exogenous drugs mimic the effects of natural endogenous hormones, such 
as the case of synthetic versions of estradiol, progesterone and testosterone: zeranol, 
melengestrol acetate (MGA) and trenbolone acetate, respectively. In general and due to their 
entirely exogenous character, since these compounds do not exist naturally, there are no 
major difficulties in determining analytic synthetic steroids. Thus, their mere presence in the 
animal organism is a clear evidence their administration. With regard to the confirmation of 
use of xenobiotic analogues of natural sex steroids and non-steroidal compounds, such as 
stilbenes and zeranol, there is an extensive range of successful methods that has been 
performed on different analytic matrices. These analytical procedures have made the 
confirmation of illicit administrations of anabolics in cattle feasible (De Brabander et al., 
2007; Duffy et al., 2009; Kaklamanos et al., 2011; Noppe et al., 2008).  
On the other hand, many veterinary hormonal preparations, although not all, consist on 
ester derivatives of the corresponding endogenous steroid, such as testosterone decanoate or 
estradiol benzoate. As hormonal esters do not naturally occur in the animal organism, the 
detection of these synthetic substances in the body of an animal provides irrefutable 
evidence of the abuse of these promoters. Although the administration of esters of natural 
hormones can be detected through hair analysis (Duffy et al., 2008; Grataco囲s-Cubarsi 囲 et al., 
2006; Pedreira et al., 2007; Rambaud et al., 2005), it has been very difficult to detect intact 
steroid esters in body fluids or tissues. It is likely that esters quickly hydrolyze in the body 
of the animal, releasing the corresponding natural hormone (Stolker et al., 2009). So, the 
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simple detection and confirmation of the presence of these semisynthetic versions are not 
always possible. That is particularly true for estradiol benzoate, which has only been 
detected in hair up to date (Duffy et al., 2009; Hooijerink et al., 2005; Rambaud et al., 2005; 
Stolker et al., 2009), because estradiol benzoate undergoes the loss of the ester group once it 
reaches the bloodstream. In order to detect the administration of these esterified substances, 
new analytical approaches are required, in the same manner that they are required to detect 
the administration of exogenous hormones in their natural chemical form (estradiol, 
testosterone or progesterone). 
6.2 Exogenous natural steroid hormones 
Hormones of natural origin, such as estradiol-17ǃ, testosterone or progesterone, are still a 
weak area in residue-monitoring plans due to their endogenous origin, as the target 
compound is always present. In such a case, the confirmation of an exogenous 
administration involves logical difficulties associated with distinguishing an exogenous 
origin from an endogenous (naturally occurring) presence of these hormones. The 
demonstration of an exogenous administration of natural steroids, such as testosterone, 
estradiol or cortisol, remains problematic. No official threshold has been stated for natural 
hormone concentrations, mainly due to the fact that concentrations of naturally occurring 
hormones are highly variable and depend on the type of animal product, breed, gender, age, 
disease, medication and physiological condition (Angeletti et al., 2006; Hartmann et al., 
1998; Le Bizec et al., 2009; Pleadin et al., 2011). The development of methods to provide 
unequivocal discrimination between the natural presence of an endogenous hormone and 
its presence as a consequence of an illegal exogenous administration remains a challenge. 
Some promising analytical approaches have been published in the past few years regarding 
this critical point of controlling residues in food of animal origin. 
7. Monitoring exogenous natural hormones: An unresolved problem 
The confirmation of an exogenous administration of natural hormones involves logical 
difficulties associated with the distinction between an exogenous origin and the natural 
presence of these endogenous hormones (synthesis in the body). In fact, it has been found 
that treatments with testosterone or estradiol in bovines lead to equal or lower plasma 
concentrations of these compounds (Scippo et al., 1994; Simontacchi et al., 2004). On the 
other hand, exogenous natural hormones are usually administered as simple semi-synthetic 
esters (i.e., 17ǃ-estradiol benzoate and testosterone decanoate) to increase their effective 
half-life. Subsequently, a rapid hydrolysis of these compounds takes place as soon as they 
reach the bloodstream, where they generate non-esterified forms that are indistinguishable 
from naturally occurring forms (Stolker et al., 2009). These exogenous natural compounds 
(or even hormonal esters) follow the same pathways as the natural compounds 
biosynthesized by the animal, making the detection and confirmation of their exogenous 
administration difficult, if not impossible. These circumstances have led to the lack of 
success in detecting hormone esters such as estradiol benzoate in serum or plasma, which 
has only been confirmed in hair from animals treated with this ester (Duffy et al., 2009; 
Regal et al., 2008). Some promising approaches have been published in recent years in 
regard to the development of methods that allow unambiguous discrimination between the 
presence of a natural endogenous hormone and its presence as a result of an illegal 
exogenous administration.  
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7.1 Approaches based on hormonal metabolism 
Up to date, it is unknown to what extent the administration of exogenous hormones interferes 
with the hormonal metabolism of the animal. When administered exogenously, natural steroid 
hormones must be metabolized in the same way and using the same metabolic pathways that 
endogenous compounds, so that the ratios of these hormones against their precursors and/or 
their metabolites may be somehow altered by the hormonal treatment (Pinel et al., 2010). This 
analytical approach is already a common practice in the supervision of doping in sports and 
horse racing (Sottas et al., 2008; Strahm et al., 2009; Torrado et al., 2008). However, the known 
approaches based on metabolic parameters that have proved to be useful in humans, as the 
ratio testosterone/epitestosterone, not seem to succeed in cattle (Angeletti et al., 2006). Early 
attempts to detect illegal hormone treatments in cattle assessing hormonal levels and levels of 
their precursors and metabolites (and hormonal ratios) appeared in plasma and urine of cattle 
(Becue et al., 2010; Fritsche et al., 1999; Simontacchi et al., 2004). In 1999, Fritsch et al. 
concluded that implants of estradiol benzoate and progesterone did not to affect the total 
concentration of steroids (precursors and metabolites) in meat from treated cattle. However, 
they encountered significant differences in 17ǃ-estradiol/17ǂ-estradiol+Estrone ratio and in 
cortisone/hydrocortisone ratio; so that the administration of natural hormones did seem to 
influence the hormonal metabolism (Fritsche et al., 1999). On the other hand, Maume et al. 
concluded that estradiol implants increased the concentration of 17ǃ-estradiol (E2) in beef, 
following a dose-dependent relationship. Besides, the concentrations of E2 and ǂE2 
glucuronides were also increased in tissues of treated animals, an effect also being dose-
dependent (Maume et al., 2003). As for the administration of steroid precursors or 
prohormones, Becue et al. recently published results in urine for cattle treated with DHEA 
orally or intramuscularly. They concluded that the administration of DHEA causes significant 
differences in overall levels of DHEA sulphate and 5-androstenediol, and also in the levels of 
free DHEA and 17ǂ-testosterone in animals treated orally. DHEA levels, both free and 
sulphate, 5-androstenediol and 17ǂ-testosterone were modified for animals treated via 
intramuscular (Becue et al., 2010).  
7.2 
13
C/
12
C isotopic ratio 
The measurement of 13C/12C ratios by gas chromatography/combustion/isotope ratio 
mass spectrometry (GC-C-IRMS) can be a powerful tool to trace the true origin of the 
steroids, and it is one of the most promising approaches to control of exogenous 
administration of natural hormones. The administration of natural hormones to cattle will 
lead to an alteration of the 13C/12C ratio of these compounds and their metabolites, 
whereas the isotopic composition remains constant for their precursors. This methodology 
has been applied successfully in urine to trace the administration of testosterone and 
estradiol esters in cattle (Buisson et al., 2005; Hebestreit et al., 2006). However, no 
thresholds of reference for these changes in the 13C/12C ratios of steroid hormones have 
been established yet, since their variations depend largely on the diet of the animal and 
also other factors such as age, sex or breed (Cawley et al., 2009; Ferchaud et al., 2000). In 
addition, GC-C-IRMS methods imply long and complicated steps of extraction and 
purification of the sample and also the use of semi-preparation HPLC and derivatization 
procedures (Buisson et al., 2005; Hebestreit et al., 2006). 
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7.3 Omic technologies: Metabolomics 
In recent years, there is a clear trend towards more intelligent procedures for data 
evaluation. New methodological approaches based on untargeted and global measurements 
are emerging strongly as analytical tools for the analysis of residues in food-producing 
animals (Pinel et al., 2010; Riedmaier et al., 2009). Traditionally, samples are analyzed 
searching for the presence of specific target analytes. Metabolomics is an emerging field 
within the omic methodologies (proteomics, transcriptomics, metabolomics) that focuses, in 
an untargeted and global scale, in the high yield measurement of small molecules (called 
metabolites) in biological matrices. These techniques are based on the physiological changes 
that are expected to appear in the animal due to the administration of an anabolic agent, and 
they are largely used to search potential biomarkers of such administration (Mooney et al., 
2008; Mooney et al., 2009; Riedmaier et al., 2009). Metabolomics is based on detecting small 
molecules and excluding big biopolymers such as proteins, generating this way a large set of 
descriptors characteristic of the biological matrix under investigation in different 
experimental groups. Metabolomic approaches have already shown to be affective in 
relation to different biochemical processes, such as drug toxicity and diseases (Brindle et al., 
2002; Coen et al., 2003; Lindon et al., 2004; Vallejo et al., 2009), prediction of gender (Lutz et 
al., 2006), nutritional effects studies (Wang et al., 2005) and even doping control in horses 
(Kieken et al., 2011) or the clenbuterol use in cattle (Courant et al., 2009). Basically, the 
general principle of metabolomic studies is the characterization of the biological system or 
sample in question through the generation of  metabolomic fingerprints.  
There are not many metabolomics studies regarding the detection of sex steroid abuse in 
livestock production, neither useful biomarkers to be used in targeted analysis. However, 
Rijk et al. developed a metabolomic strategy of screening in urine for bovine animals treated 
with DHEA and pregnenolone. This methodology is an useful tool to track the abuse of 
these prohormones, but their reference levels remain unknown, making difficult their use in 
targeted analysis, at least until the metabolites of this non-focused approach are elucidated  
(Rijk et al., 2009). On the other hand, Dervilly-Pinel et al. recently published a metabolomic 
study in urine for cattle treated with a combination of estradiol benzoate and nandrolone 
laureate. These authors proved the existence of changes in urinary metabolomic profiles of 
animals treated with steroids, when comparing them with control animals, opening the door 
to possible screening strategies. Dervilly-Pinel et al. also stated the importance of several 
potential biomarkers in the discrimination of hormonally treated animals from control cattle 
(Dervilly-Pinel et al., 2011). 
There is a range of analytical platforms which could be employed in metabolomics to collect 
data, including gas chromatography-mass spectrometry (GC-MS), liquid chromatography-
mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR) spectrometry, just to 
extract as much information as possible from the matrix of interest. Traditionally, NMR has 
played a key role in the development of metabolomics and was the preferred analytical tool. 
However, due to the higher sensitivity compared to NMR and the increasing reproducibility 
of today´s GC-MS and LC-MS systems, the have become important analytical platforms for 
all types of metabolomic applications (Brown et al., 2009; Lutz et al., 2006). By coupling high 
chromatography separation with different mass spectrometric techniques, the partial or 
complete separation of metabolites prior to detection is achieved. To this end, gas 
chromatography was first used, however, the necessary thermal stability of the investigated 
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compounds, the required derivatization of non-volatile compounds prior to analysis and the 
frequent absence of molecular ions have made liquid chromatography coupled to 
atmospheric-pressure ionization a more and more used tool for metabolomics. Last 
generation of high resolution devices including time of flight and orbitrap instruments are 
becoming more and more used in this field due to their high performance in terms of 
sensitivity and specificity (Dunn et al., 2008; Scheltema et al., 2008).  
Moreover, due to the large amount of data generated during metabolomic fingerprinting, 
bioinformatics tools are required for processing and analysing this huge volume of complex 
data. Several software solutions are today available either with free access (XCMS, MZmine, 
Metalign, MathDAMP, COMSPARI and METIDEA) or commercially (SIEVE from Thermo 
Fisher Scientific, Markerlynx from Waters, GeneSpring from Agilent and MarkerView from 
MSDSciex). Data processing is composed of four major steps; background noise correction, 
peak alignment, peak deconvolution and peak sorting. Then, resulting data are of 
multivariate character, since metabolomic procedures handle several hundreds to thousands 
of variables/metabolites. Thus the use of multivariate statistical techniques are required to 
analyse such data set and finally to point out potential signals (i.e. biomarkers) of interest. 
Principal component analysis (PCA) has become a popular tool for visualizing datasets and 
for extracting relevant information, as well as partial least-squares projection to latent 
structures (PLS) (Eriksson et al., 2004). Recently, the Orthogonal PLS methodology (OPLS) 
has shown to be useful for elucidating differences between many samples and many 
variables (Pohjanen et al., 2007; Werner et al., 2008). 
8. References  
Adebamowo, C. A.; Spiegelman, D.; Berkey, C. S.; Danby, F. W.; Rockett, H. H.; Colditz, G. 
A.; Willett, W.C. & Holmes, M.D. (2008). Milk consumption and acne in teenaged 
boys. Journal of the American Academy of Dermatology, Vol.58, No.5, pp. 787-793.  
Aksglaede, L.; Juul, A.; Leffers, H.; Skakkebæk, N. E. & Andersson, A. (2006). The sensitivity 
of the child to sex steroids: Possible impact of exogenous estrogens. Human 
Reproduction Update, Vol.12, No.4, pp. 341-349.  
Alves, C.; Flores, L. C.; Cerqueira, T. S. & Toralles, M. B. P. (2007). Environmental exposure 
to endocrine disruptors with estrogenic activity and the association with pubertal 
disorders in children. Cadernos Saude Publica, Vol.23, No.5, pp. 1005-1014.  
Angeletti, R.; Contiero, L.; Gallina, G. & Montesissa, C. (2006). The urinary ratio of 
testosterone to epitetosterone: A good marker of illegal treatment also in cattle? 
Veterinary Research Communications, Vol.30, Suppl.1, pp. 127-131.  
Auclair, C. A. (1979). Consequences of prenatal exposure to diethylstilbestrol. Journal of 
Obstetric, Gynecologic, and Neonatal Nursing, Vo.8, No.1, pp. 35-39.  
Bay, K.; Andersson, A. & Skakkebaek, N. E. (2004). Estradiol levels in prepubertal boys and 
girls - analytical challenges. International Journal of Andrology, Vol.27, No.5, pp. 266-
273.  
Becue, I.; Van Poucke, C.; Rijk, J. C. W.; Bovee, T. F. H.; Nielen, M. & Van Peteghem, C. 
(2010). Investigation of urinary steroid metabolites in calf urine after oral and 
intramuscular administration of DHEA. Analytical and Bioanalytical Chemistry, 
Vol.396, pp. 799-808.  
www.intechopen.com
 
Natural Hormones in Food-Producing Animals: Legal Measurementsand Analytical Implications 
 
221 
Boles, J. A.; Boss, D. L.; Neary, K. I.; Davis, K. C. & Tess, M. W. (2009). Growth implants 
reduced tenderness of steaks from steers and heifers with different genetic 
potentials for growth and marbling. Journal of Animal Science, Vol.87, pp. 269-274.  
Brindle, J. T.; Antti, H.; Holmes, E.; Tranter, G.; Nicholson, J. K.; Bethell, H. W. L.; Clarke, S.; 
Schofield, P.M.; McKilligan, E.; Mosedale, D.E. & Grainger, D.J. (2002). Rapid and 
non-invasive diagnosis of the presence and severity of coronary heart disease using 
1H NMR -based metabonomics. Nature Medicine, Vol.8, No.12, pp. 1439-1444.  
Brown, M.; Dunn, W. B.; Dobson, P.; Patel, Y.; Winder, C. L.; Francis-McIntyre, S.; Begley, P.; 
Carroll, K.; Broadhurst, D.; Tseng, A.; Swainston, N.; Spasic, I.; Goodacre, R. & Kell, 
D.B. (2009). Mass spectrometry tools and metabolite-specific databases for 
molecular identification in metabolomics. Analyst, Vol.134, No.7, pp. 1322-1332.  
Buisson, C.; Hebestreit, M.; Weigert, A. P.; Heinrich, K.; Fry, H.; Flenker, U.; Banneke, S.; 
Prevost, S.; Andre, F.; Schaenzer, W.; Houghton, E. & Le Bizec, B. (2005). 
Application of stable carbon isotope analysis to the detection of 17 beta-estradiol 
administration to cattle. Journal of Chromatography A, Vol.1093, No.1-2, pp. 69-80.  
Burkea, C. R.; Mussardb, M. L.; Grumb, D. E. & Day, M. L. (2001). Effects of maturity of the 
potential ovulatory follicle on induction of oestrus and ovulation in cattle with 
oestradiol benzoate. Animal Reproduction Science, Vol.66, No.3-4, pp. 161-174. 
Cavalieri, J.; Rabiee, A. R.; Hepworth, G. & Macmillan, K. L. (2005). Effect of artificial 
insemination on submission rates of lactating dairy cows synchronised and 
resynchronised with intravaginal progesterone releasing devices and oestradiol 
benzoate. Animal Reproduction Science, Vol.90, No.1-2, pp. 39-55.  
Cawley, A. T.; Trout, G. J.; Kazlauskas, R.; Howe, C. J. & George, A. V. (2009). Carbon 
isotope ratio (δ13C) values of urinary steroids for doping control in sport. Steroids, 
Vol.74, pp. 379-392.  
Cesario, S. K. & Hughes, L. A. (2007). Precocious puberty: A comprehensive review of 
literature. Journal of Obstetric, Gynecologic, & Neonatal Nursing, Vol.36, No.3, pp. 263-
274.  
Chen, T. T.; Huang, C. C.; Lee, T. Y.; Lin, K. J.; Chang, C. C. & Chen, K. L. (2010). Effect of 
caponization and exogenous androgen implantation on muscle characteristics of 
male chickens. Poultry Science, Vol.89, No.3, pp. 558-563.  
Coen, M.; Lenz, E. M.; Nicholson, J. K.; Wilson, I. D.; Pognan, F. & Lindon, J. C. (2003). An 
integrated metabonomic investigation of acetaminophen toxicity in the mouse 
using NMR spectroscopy. Chemical Research in Toxicology, Vol.16, No.3, pp. 295-303.  
Courant, F.; Aksglaede, L.; Antignac, J.P.; Monteau, F.; Sorensen, K.; Andersson, A.; 
Skakkebaek, N.; Juul, A. & Le Bizec, B. (2010). Assessment of circulating sex steroid 
levels in prepubertal and pubertal boys and girls by a novel ultrasensitive gas 
chromatography-tandem mass spectrometry method. Journal of Clinical 
Endocrinology and Metabolism, Vol.95, No.1, pp. 82-92.  
Courant, F.; Antignac, J.P.; Laille, J.; Monteau, F.; Andre, F. & Le Bizec, B. (2008). Exposure 
assessment of prepubertal children to steroid endocrine disruptors, 2: 
Determination of steroid hormones in milk, egg, and meat samples. Journal of 
Agricultural and Food Chemistry, Vol.56, No.9, pp. 3176-3184.  
Courant, F.; Antignac, J.P.; Maume, D.; Monteau, F.; Andre, F. & Le Bizec, B. (2007). 
Determination of naturally occurring oestrogens and androgens in retail samples of 
milk and eggs. Food Additives and Contaminants, Vol.24, No.12, pp. 1358-1366.  
www.intechopen.com
 
Food Production – Approaches, Challenges and Tasks 
 
222 
Courant, F.; Pinel, G.; Bichon, E.; Monteau, F.; Antignac, J.P. & Le Bizec, B. (2009). 
Development of a metabolomic approach based on liquid chromatography-high 
resolution mass spectrometry to screen for clenbuterol abuse in calves. Analyst, 
Vol.134, pp. 1637-1646.  
Cousins, L.; Karp, W.; Lacey, C. & Lucas, W. E. (1980). Reproductive outcome of women 
exposed to diethylstilbestrol in utero. Obstetrics and Gynecology, Vol.56, No.1, pp. 
70-76.  
Daeseleire, E.; Vanoosthuyze, K. & Van Peteghem, C. (1994). Application of high-
performance thin-layer chromatography and gas chromatography-mass 
spectrometry to the detection of new anabolic steroids used as growth promoters in 
cattle fattening. Journal of Chromatography A, Vol.674, No.1-2, pp. 247-253.  
Daxenberger, A.; Ibarreta, D. & Meyer, H. H. D. (2001). Possible health impact of animal 
oestrogens in food. Human Reproduction Update, Vol.7, No.3, pp. 340-355.  
De Brabander, H. F.; Le Bizec, B.; Pinel, G.; Antignac, J.P.; Verheyden, K.; Mortier, V.; 
Courtheyn, D. & Noppe, H. (2007). Past, present and future of mass spectrometry 
in the analysis of residues of banned substances in meat-producing animals. Journal 
of Mass Spectrometry, Vol.42, No.8, pp. 983-998.  
Dervilly-Pinel, G.; Weigel, S.; Lommen, A.; Chereau, S.; Rambaud, L.; Essers, M.; Antignac, 
J.P.; Nielen, M.W.F. & Le Bizec, B. (2011). Assessment of two complementary liquid 
chromatography coupled to high resolution mass spectrometry metabolomics 
strategies for the screening of anabolic steroid treatment in calves. Analytica Chimica 
Acta, Vol.700, No.1-2, pp. 144-154.  
Dikeman, M. E. (2007). Effects of metabolic modifiers on carcass traits and meat quality. 
Meat Science, Vol.77, No.1, pp. 121-135.  
Draisci, R.; Palleschi, L.; Ferretti, E.; Lucentini, L. & Cammarata, P. (2000). Quantitation of 
anabolic hormones and their metabolites in bovine serum and urine by liquid 
chromatography–tandem mass spectrometry. Journal of Chromatography A, Vol.870, 
No.1-2, pp. 511-522.  
Duffy, E.; Rambaud, L.; Le Bizec, B. & O'Keeffe, M. (2009). Determination of hormonal 
growth promoters in bovine hair: Comparison of liquid chromatography-mass 
spectrometry and gas chromatography-mass spectrometry methods for estradiol 
benzoate and nortestosterone decanoate. Analytica Chimica Acta, Vol.637, No.1-2, 
pp. 165-172.  
Duffy, E. F.; Danaher, M. & O'Keeffe, M. (2008). Determination of steroid esters in bovine hair 
using LC-MS/MS. Proceedings of the EuroResidue VI (Conference on Residues of Veterinary 
Drugs in Food), Vol. 3, pp. 1025-1030.  
Dunn, W. B.; Broadhurst, D.; Brown, M.; Baker, P. N.; Redman, C. W. G.; Kenny, L. C. & Kell, D.B. 
(2008). Metabolic profiling of serum using ultra performance liquid chromatography and 
the LTQ-orbitrap mass spectrometry system. Journal of Chromatography B, Vol.871, No.2, 
pp. 288-298.  
EEC (1988a). Directive 81/602/EEC. Official Journal of the European Communities, No.L222, pp. 32-33. 
EEC (1988b). Directive 88/299/EEC. Official Journal of the European Communities, No.L128, pp. 36-38. 
EC (1996a). Directive 96/22/EC. Official Journal of the European Communities, No.L125, pp. 3-9.  
EC (1996b). Directive 96/23/EC. Official Journal of the European Communities, No.L125, pp. 10-32. 
EC (2002). Decision 2002/657/EC. Official Journal of the European Union, No.L221, pp. 8-36.  
EC (2003). Directive 2003/74/EC. Official Journal of the European Union, No.L262, pp. 17-21. 
www.intechopen.com
 
Natural Hormones in Food-Producing Animals: Legal Measurementsand Analytical Implications 
 
223 
EC (2008). Directive 2008/97/EC. Official Journal of the European Union, No.L318, pp. 9-11. 
Eriksson, L.; Antti, H.; Gottfries, J.; Holmes, H.; Johansson, E.; Lindgren, F.; Long, I.; Lundstedt, 
T.; Trygg, J. & Wold, S. (2004). Using chemometrics for navigating in the large data sets 
of genomics, proteomics and metabolomics (gpm). Analytical and Bioanalytical Chemistry, 
Vol.380, pp. 419-429.  
European Commission, Directorate General for Health & Consumers (2004). 
SANCO/2004/2726rev1: Guidelines for the implementation of Decision 2002/657/EC.  
Farlow, D. W.; Xu, X. & Veenstra, T. D. (2009). Quantitative measurement of endogenous 
estrogen metabolites, risk-factors for developement of breast cancer, in commercial 
milk products by LC-MS/MS. Journal of Chromatography B, Vol.877, pp. 1327-1334.  
Ferchaud, V.; Le Bizec, B.; Monteau, F. & Andre, F. (2000). Characterization of exogenous 
testosterone in livestock by gas chromatography/combustion/isotope ratio mass 
spectrometry: Influence of feeding and age. Rapid Communications in Mass 
Spectrometry, Vol.14, No.8, pp. 652-656.  
Foster, P. A.; Chander, S. K.; Parsons, M. F. C.; Newman, S. P.; Woo, L. W. L.; Potter, B. V. L.; 
Reed, M.J. & Purohit, A. (2008). Efficacy of three potent steroid sulfatase inhibitors: 
Pre-clinical investigations for their use in the treatment of hormone-dependent 
breast cancer. Breast Cancer Research and Treatment, Vol.111, No.1, pp. 129-138.  
Fritsche, S.; Rumsey, T.; Meyer, H.; Schmidt, G. & Steinhart, H. (1999). Profiles of steroid 
hormones in beef from steers implanted with synovex-S (estradiol benzoate and 
progesterone) in comparison to control steers. Zeitschrift Für 
Lebensmitteluntersuchung Und -Forschung A, Vol.208, No.5-6, pp. 328-331.  
Ganmaa, D., Cui, X., Feskanich, D., Hankinson, S. E., & Willett, W. C. (2011). Milk, dairy 
intake and risk of endometrial cancer: A twenty six-year follow-up. International 
Journal of Cancer, (DOI: 10.1002/ijc.26265).  
Ganmaa, D. & Sato, A. (2005). The possible role of female sex hormones in milk from 
pregnant cows in the development of breast, ovarian and corpus uteri cancers. 
Medical Hypotheses, Vol.65, No.6, pp. 1028-1037.  
Ganmaa, D.; Wang, P. Y.; Qin, L. Q.; Hoshi, K. & Sato, A. (2001). Is milk responsible for male 
reproductive disorders? Medical Hypotheses, Vol.57, No.4, pp. 510-514.  
Garner, B.; Phassouliotis, C.; Phillips, L. J.; Markulev, C.; Butselaar, F.; Bendall, S.; Yung, Y. 
& McGorry, P.D. (2011). Cortisol and dehydroepiandrosterone-sulphate levels 
correlate with symptom severity in first-episode psychosis. Journal of Psychiatric 
Research, Vol.45, No.2, pp. 249-255.  
Givens, D. I.; Morgan, R. & Elwood, P. C. (2008). Relationship between milk consumption 
and prostate cancer: A short review. Nutrition Bulletin, Vol.33, pp. 279-286.  
Grataco 囲s-Cubarsi囲, M.; Castellari, M.; Valero, A. & Garci囲a-Regueiro, J. A. (2006). Hair analysis 
for veterinary drug monitoring in livestock production. Journal of Chromatography B, 
Vol.834, No.1-2, pp. 14-25.  
Haney, A. F. & Hammond, M. G. (1983). Infertility in women exposed to diethylstilbestrol in 
utero. Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol.28, 
No.12, pp. 851-856.  
Hartmann, S.; Lacorn, M. & Steinhart, H. (1998). Natural occurrence of steroid hormones in 
food. Food Chemistry, Vol.62, No.1, pp. 7-20.  
Hebestreit, M.; Flenker, U. ; Buisson, C.; Andre, F.; Le Bizec, B.; Fry, H.; Lang, M.; Weigert, 
A.P.; Heinrich, K.; Hird, S. & Schanzer, W. (2006). Application of stable carbon 
www.intechopen.com
 
Food Production – Approaches, Challenges and Tasks 
 
224 
isotope analysis to the detection of testosterone administration to cattle. Journal of 
Agricultural and Food Chemistry, Vol.54, No.8, pp. 2850-2858.  
Herman-Giddens, M. E.; Slora, E. J.; Wasserman, R. C.; Bourdony, C. J.; Bhapkar, M. V.; 
Koch, G. G. & Hasemeier, C.M. (1997). Secondary sexual characteristics and menses 
in young girls seen in office practice: A study from the pediatric research in office 
settings network. Pediatrics, Vol.99, No.4, pp. 505-512.  
Hooijerink, H.; Lommen, A.; Mulder, P. P. J.; Van Rhijn, J. A. & Nielen, M. W. F. (2005). 
Liquid chromatography-electrospray ionisation-mass spectrometry based method 
for the determination of estradiol benzoate in hair of cattle. Analytica Chimica Acta, 
Vol.529, (1-2 SPEC. ISS.), pp. 167-172.  
Hunter R.A. (2010). Hormonal growth promotant use in the australian beef industry. Animal 
Production Science, Vol.50, pp. 637-659.  
Huyghe, E.; Matsuda, T. & Thonneau, P. (2003). Increasing incidence of testicular cancer 
worldwide: A review. Journal of Urology, Vol.170; No.1, pp. 5-11.  
Igo, J. L.; Brooks, J. C.; Johnson, B. J.; Starkey, J.; Rathmann, R. J.; Garmyn, A. J.; Nichols, 
W.T.; Hutcheson, J.P. & Miller, M.F. (2011). Characterization of estrogen-trenbolone 
acetate implants on tenderness and consumer acceptability of beef under the effect 
of 2 aging times. Journal of Animal Science, Vol.89, No.3, pp. 792-797.  
Kaaks, R.; Rinaldi, S.; Key, T. J.; Berrino, F.; Peeters, P. H. M.; Biessy, C. et al. (2005). 
Postmenopausal serum androgens, oestrogens and breast cancer risk: The 
european prospective investigation into cancer and nutrition. Endocrine-Related 
Cancer, 12(4), 1071-1082.  
Kaklamanos, G.; Theodoridis, G.; Papadoyannis, I. N. & Dabalis, T. (2007). Determination of 
anabolic steroids in muscle tissue by liquid chromatography-tandem mass 
spectrometry. Journal of Agricultural and Food Chemistry, Vol.55, No.21, pp. 8325-
8330.  
Kaklamanos, G.; Theodoridis, G. A.; Dabalis, T. & Papadoyannis, I. (2011). Determination of 
anabolic steroids in bovine serum by liquid chromatography–tandem mass 
spectrometry. Journal of Chromatography B, Vol.879, No.2, pp. 225-229.  
Kaklamanos, G.; Theodoridis, G. & Dabalis, T. (2009a). Determination of anabolic steroids in 
bovine urine by liquid chromatography–tandem mass spectrometry. Journal of 
Chromatography B, Vol.877, No.23, pp. 2330-2336.  
Kaklamanos, G.; Theodoridis, G. & Dabalis, T. (2009b). Gel permeation chromatography 
clean-up for the determination of gestagens in kidney fat by liquid 
chromatography–tandem mass spectrometry and validation according to 
2002/657/EC. Journal of Chromatography A, Vol.1216, No.46, pp. 8067-8071.  
Kieken, F.; Pinel, G.; Antignac, J.P.; Paris, A.; Garcia, P.; Popot, M. G.; Grall, M.; Mercadier, 
V.; Toutain, P.L. ; Bonnaire, Y. & Le Bizec, B. (2011). Generation and processing of 
urinary and plasmatic metabolomic fingerprints to reveal an illegal administration 
of recombinant equine growth hormone from LC-HRMS measurements. 
Metabolomics, Vol.7, No.1, pp. 84-93.  
Kushnir, M. M.; Blamires, T.; Rockwood, A. L.; Roberts, W. L.; Yue, B.; Erdogan, E.; Bunker, 
A.M. & Meikle, A.W. (2010). Liquid chromatography-tandem mass spectrometry 
assay for androstenedione, dehydroepiandrosterone, and testosterone with 
pediatric and adult reference intervals. Clinical Chemistry, Vol.56, No.7, pp. 1138-
1147.  
www.intechopen.com
 
Natural Hormones in Food-Producing Animals: Legal Measurementsand Analytical Implications 
 
225 
Kvarnryd, M.; Grabic, R.; Brandt, I. & Berg, C. (2011). Early life progestin exposure causes 
arrested oocyte development, oviductal agenesis and sterility in adult xenopus 
tropicalis frogs. Aquatic Toxicology, Vol.103, No.1-2, pp.18-24.  
Lane, E. A.; Austin, E. J. & Crowe, M. A. (2008). Oestrous synchronisation in cattle-current 
options following the EU regulations restricting use of oestrogenic compounds in 
food-producing animals: A review. Animal Reproduction Science, Vol.109, No.1-4, 
pp. 1-16.  
Le Bizec, B.; Pinel, G. & Antignac, J. (2009). Options for veterinary drug analysis using mass 
spectrometry. Journal of Chromatography A, Vol.1216. No.46, pp. 8016-8034.  
Lee, C. Y.; Lee, H. P.; Jeong, J. H.; Baik, K. H.; Jin, S. K.L; Lee, J. H. & Sohnt, S.H. (2002). 
Effects of restricted feeding, low-energy diet, and implantation of trenbolone 
acetate plus estradiol on growth, carcass traits, and circulating concentrations of 
insulin-like growth factor (IGF)-I and IGF-binding protein-3 in finishing barrows. 
Journal of Animal Science, Vol.80, No.1, pp. 84-93.  
Levy, L. S. (2010). CHAPTER 1. The use of hormomally active substances in veterinary and 
zootechnical uses – the continuing scientific and regulatory challenges. In : Analyses 
for hormonal substances in food-producing animals, J.F. Kay (Ed.), The Royal Society of 
Chemistry.  
Lindon, J. C.; Holmes, E.; Bollard, M. E.; Stanley, E. G. & Nicholson, J. K. (2004). 
Metabonomics technologies and their applications in physiological monitoring, 
drug safety assessment and disease diagnosis. Biomarkers, Vol.9, No.1, pp. 1-31.  
Loizzo, A. (1984). The case of diethylstilbestrol treated veal contained in homogenized baby-
foods in italy. Methodological and toxicological aspects. Annali Dell'Istituto 
Superiori Di Sanità, Vol.20, No.2-3, pp. 215.  
Loizzo, A.; Gatti, G. L.; Macri, A.; Moretti, G.; Ortolani, E. & Palazzesi, S. (1984). Italian baby 
food containing diethylstilbestrol - 3 years later. Lancet, Vol.1, No.8384, pp. 1014-
1015.  
Lukanova, A.; Lundin, E.; Micheli, A.; Arslan, A.; Ferrari, P.; Rinaldi, S.; Krogh, V.; Lenner, 
P.; Shore, R.E.; Biessy, C.; Muti, P.; Riboli, E.; Koenig, K.; Levitz, M.; Stattin, P.; 
Berrino, F.; Hallmans, G.; Kaaks, R.; Toniolo, P. & Zeleniuch-Jacquotte, A. (2004). 
Circulating levels of sex steroid hormones and risk of endometrial cancer in 
postmenopausal women. International Journal of Cancer, Vol.108, No.3, pp. 425-432.  
Lusk, J. L. & Fox, J. A. (2002). Consumer demand for mandatory labeling of beef from cattle 
administered growth hormones or fed genetically modified corn. Journal of 
Agricultural and Applied Economics, Vol.34, No.1, pp. 27-38.  
Lutz, U. ; Lutz, R. W. & Lutz, W. K. (2006). Metabolic profiling of glucuronides in human 
urine by LC-MS/MS and partial least-squares discriminant analysis for 
classification and prediction of gender. Analytical Chemistry, Vol.78, No.13, pp. 
4564-4571.  
Martínez, M. F.; Kastelic, J. P.; Adams, G. P.; Cook, B.; Olson, W. O. & Mapletoft, R. J. (2002). 
The use of progestins in regimens for fixed-time artificial insemination in beef 
cattle. Theriogenology, Vol.57, No.3, pp. 1049-1059.  
Maruyama, K.; Oshima, T. & Ohyama, K. (2010). Exposure to exogenous estrogen through 
intake of commercial milk produced from pregnant cows. Pediatrics International, 
Vol.52, No.1, pp. 33-38.  
www.intechopen.com
 
Food Production – Approaches, Challenges and Tasks 
 
226 
Maume, D.; Deceuninck, Y.; Pouponneau, K.; Paris, A.; Le Bizec, B. & André, F. (2001). 
Assessment of estradiol and its metabolites in meat. Acta Pathologica, Microbiologica 
et Immunologica Scandinavica, Vol.109, No.1, pp. 32-38.  
Maume, D.; Le Bizec, B.; Pouponneau, K.; Deceuninck, Y.; Solere, V.; Paris, A.; Antignac, J.P. 
& André, F. (2003). Modification of 17ǃ-estradiol metabolite profile in steer edible 
tissues after estradiol implant adminsitration. Analytica Chimica Acta, Vol.483, pp. 
289-297.  
McPhee, M. J.; Oltjen, J. W.; Famula, T. R. & Sainz, R. D. (2006). Meta-analysis of factors 
affecting carcass characteristics of feedlot steers. Journal of Animal Science, Vol.84, 
pp. 3143-3154.  
Meireles, S. I.; Esteves, G. H.; Hirata, R.; Peri, S.; Devarajan, K.; Slifker, M.; Mosier, S.L.; 
Peng, J.; Vadhanam, M.V.; Hurst, H.E.; Neves, E.J.; Reis, L.F.; Gairola, C.G.; Gupta, 
R.C. & Clapper, M.L. (2010). Early changes in gene expression induced by tobacco 
smoke: Evidence for the importance of estrogen within lung tissue. Cancer 
Prevention Research, Vol.3, No.6, pp. 707-717.  
Melnik, B. C. (2009). Milk - the promoter of chronic western diseases. Medical Hypotheses, 
Vol.72, No.6, pp. 631-639.  
Micheli, A.; Muti, P. ; Secreto, G.; Krogh, V.; Meneghini, E.; Venturelli, E.; Sieri, S.; Pala, V. & 
Berrino, F. (2004). Endogenous sex hormones and subsequent breast cancer in 
premenopausal women. International Journal of Cancer, Vol.112, No.2, pp. 312-318.  
Moal, V.; Mathieu, E.; Reynier, P.; Malthie 偉ry, Y. & Gallois, Y. (2007). Low serum testosterone 
assayed by liquid chromatography-tandem mass spectrometry. Comparison with 
five immunoassay techniques. Clinica Chimica Acta, Vol.386, No.1-2, pp. 12-19.  
Mooney, M. H.; Elliott, C. T. & Le Bizec, B. (2009). Combining biomarker screening and 
mass-spectrometric analysis to detect hormone abuse in cattle. Trends in Analytical 
Chemistry, Vol.28, No.6, pp. 665-675.  
Mooney, M. H.; Situ, C.; Cacciatore, G.; Hutchinson, T.; Elliott, C. & Bergwerff, A. A. (2008). 
Plasma biomarker profiling in the detection of growth promoter use in calves. 
Biomarkers, Vol.13, No.3, pp. 246-256.  
Nelson, R. E.; Grebe, S. K.; O'Kane, D. J. & Singh, R. J. (2004). Liquid chromatography - 
tandem mass spectrometry assay for simultaneous measurement of estradiol and 
estrone in human plasma. Clinical Chemistry, Vol.50, No.2, pp. 373-384.  
Noppe, H.; Le Bizec, B.; Verheyden, K. & De Brabander, H. F. (2008). Novel analytical 
methods for the determination of steroid hormones in edible matrices. Analytica 
Chimica Acta, Vol.611, No.1, pp. 1-16.  
Pape-Zambito, D. A.; Roberts, R. F. & Kensinger, R. S. (2010). Estrone and 17ǃ-estradiol 
concentrations in pasteurized-homogenized milk and commercial dairy products. 
Journal of Dairy Science, Vol.93, No.6, pp. 2533-2540.  
Parent, A.; Teilmann, G.; Juul, A.; Skakkebaek, N. E.; Toppari, J. & Bourguignon, J. (2003). 
The timing of normal puberty and the age limits of sexual precocity: Variations 
around the world, secular trends, and changes after migration. Endocrine Reviews, 
Vol.24, No.5, pp. 668-693.  
Parr, S. L.; Chung, K. Y.; Hutcheson, J. P.; Nichols, W. T.; Yates, D. A.; Streeter, M. N.; 
Swingle, R.S.; Galyean, M.L. & Johnson, B.J. (2011). Dose and release pattern of 
anabolic implants affects growth of finishing beef steers across days on feed. Journal 
of Animal Science, Vol.89, No.3, pp. 863-873.  
www.intechopen.com
 
Natural Hormones in Food-Producing Animals: Legal Measurementsand Analytical Implications 
 
227 
Partsch, C. & Sippell, W. G. (2001). Pathogenesis and epidemiology of precocious puberty. 
effects of exogenous oestrogens. Human Reproduction Update, Vol.7, No.3, pp. 292-
302.  
Pedreira, S.; Lolo, M.; Va 囲zquez, B. I.; Franco, C. M.; Cepeda, A. & Fente, C. (2007). Liquid 
chromatography-electrospray ionization-mass spectrometry method in multiple 
reaction monitoring mode to determine 17ǂ-ethynylestradiol residues in cattle hair 
without previous digestion. Journal of Agricultural and Food Chemistry, Vol.55, No.23, 
pp. 9325-9329.  
Pinel, G.; Weigel, S.; Antignac, J.P.; Mooney, M. H.; Elliott, C.; Nielen, M. W. F. & Le Bizec, 
B. (2010). Targeted and untargeted profiling of biological fluids to screen for 
anabolic practices in cattle. Trends in Analytical Chemistry, Vol.29, No.11, pp. 1269-
1280.  
Pleadin, J.; Terzić, S.; Perši, N. & Vulić, A. (2011). Evaluation of steroid hormones anabolic 
use in cattle in croatia. Biotechnology in Animal Husbandry, Vol.7, No.2, pp. 7-2.  
Poelmans, S.; De Wasch, K.; Noppe, H.; Van Hoof, N.; Van Cruchten, S.; Le Bizec, B.; 
Deceuninck, Y.; Sterk, S.; Van Rossum, H.J.; Hoffman, M.K. & De Brabander, H.F. 
(2005a). Endogenous occurrence of some anabolic steroids in swine matrices. Food 
Additives and Contaminants, Vol.22, No.9, pp. 808-815.  
Poelmans, S.; De Wasch, K.; Noppe, H.; Van Hoof, N.; Van De Wiele, M.; Courtheyn, D.; 
Gillis, W.; Vanthemsche, P.; Janssen, C.R. & De Brabander, H.F. (2005b). 
Androstadienetrione, a boldenone-like component, detected in cattle faeces with 
GC-MSn and LC-MSn. Food Additives and Contaminants, Vol.22, No.9, pp. 798-807.  
Pohjanen, E.; Thysell, E.; Jonsson, P.; Eklund, C.; Silfver, A.; Carlsson, I.B.; Lundgren, K.; 
Moritz, T.; Svensson, M.B. & Antti, H. (2007). A multivariate screening strategy for 
investigating metabolic effects of strenuous physical exercise in human serum. 
Jounal of Proteome Research, Vol.6, No.6, pp. 2113-2120.  
Prins, G. S. (2008). Endocrine disruptors and prostate cancer risk. Endocrine-Related Cancer, 
Vol.15, No.3, pp. 649-656.  
Rambaud, L.; Bichon, E.; Cesbron, N.; Andre囲, F. & Le Bizec, B. (2005). Study of 17ǃ-estradiol-
3-benzoate, 17ǂ-methyltestosterone and medroxyprogesterone acetate fixation in 
bovine hair. Analytica Chimica Acta, Vol.532, No.2, pp. 165-176.  
Regal, P.; Vázquez, B. I.; Franco, C. M.; Cepeda, A. & Fente, C. A. (2008). Development of a 
rapid and confirmatory procedure to detect 17ǃ-estradiol 3-benzoate treatments in 
bovine hair. Journal of Agricultural and Food Chemistry, Vol.56, No.24, pp. 11607-
11611.  
Riedmaier, I.; Becker, C.; Pfaffl, M. W. & Meyer, H. H. D. (2009). The use of omic 
technologies for biomarker development to trace functions of anabolic agents. 
Journal of Chromatography A, Vol.1216, pp. 8192-8199.  
Rijk, J. C. W.; Lommen, A.; Essers, M. L.; Groot, M. J.; Van Hende, J. M.; Doeswijk, T. G. & 
Nielen, M.W.F. (2009). Metabolomics approach to anabolic steroid urine profiling 
of bovines treated with prohormones. Analytical Chemistry, Vol.81, No.16, pp. 6879-
6888.  
Rosenfeld, D. L. & Bronson, R. A. (1980). Reproductive problems in the DES-exposed female. 
Obstetrics and Gynecology, Vol.55, No.4, pp. 453-456.  
Salman, M.; New, J. C. J.; Bailey, M.; Brown, C.; Detwiler, L.; Galligan, D.; Hall, C.; Kennedy, 
M.; Lonergan, G.; Mann, L.; Renter, D.; Saeed, M.; White, B. & Zika, S. (2008). 
www.intechopen.com
 
Food Production – Approaches, Challenges and Tasks 
 
228 
Global food systems and public health: Production methods and animal 
husbandry, A national commission on industrial farm animal production report. 
pew commission on industrial farm animal production. In: Comparative Medicine 
Publications and Other Works, 01.09.2011, Available from 
http://trace.tennessee.edu/utk_compmedpubs/32 
Scheffler, J. M.; Buskirk, D. D.; Rust, S. R.; Cowley, J. D. & Doumit, M. E. (2003). Effect of 
repeated administration of combination trenbolone acetate and estradiol implants 
on growth, carcass traits, and beef quality of long-fed holstein steers. Journal of 
Animal Science, Vol.81, pp. 2395-2400.  
Scheltema, R. A.; Kamleh, A.; Wildridge, D.; Ebikeme, C.; Watson, D. G.; Barrett, M. R.; 
Jansen, R.C. & Breitling, R. (2008). Increasing the mass accuracy of high-resolution 
LC-MS data using background ions - a case study on the LTQ-orbitrap. Proteomics, 
Vol.8, No.22, pp. 4647-4656.  
Scippo, M.; Degand, G.; Duyckaerts, A.; Maghuin-Rogister, G. & Delahaut, P. (1994). Control 
of the illegal administration of natural steroid hormones in the plasma of bulls and 
heifers. Analyst, Vol.119, No.12, pp. 2639-2644.  
Senger, P. L. (1994). The estrus detection problem: New concepts, technologies, and 
possibilities Journal of Dairy Science, Vol.77, No.9, pp. 2745-2753.  
Shao, B.; Zhao, R.; Meng, J.; Xue, Y.; Wu, G.; Hu, J. & Tu, X. (2005). Simultaneous 
determination of residual hormonal chemicals in meat, kidney, liver tissues and 
milk by liquid chromatography-tandem mass spectrometry. Analytica Chimica Acta, 
Vol.548, No.1-2, pp. 41-50.  
Shatalova, E. G.; Klein-Szanto, A. J. P.; Devarajan, K.; Cukierman, E. & Clapper, M. L. (2011). 
Estrogen and cytochrome P450 1B1 contribute to both early- and late-stage head 
and neck carcinogenesis. Cancer Prevention Research, Vol.4, No.1, pp. 107-115.  
Sheridan, P. J.; Austin, F. H.; Bourke, S. & Roche, J. F. (1990). The effect of anabolic agents on 
growth rate and reproductive organs of pigs. Livestock Production Science, Vol.26, 
No.4, pp. 263-275.  
Simontacchi, C.; Perez De Altamirano, T.; Marinelli, L.; Angeletti, R. & Gabai, G. (2004). 
Plasma steroid variations in bull calves repeatedly treated with testosterone, 
nortestosterone and oestradiol administered alone or in combination. Veterinary 
Research Communications, Vol.28, No.6, pp. 467-477.  
Sorwell, K. G. & Urbanski, H. F. (2010). Dehydroepiandrosterone and age-related cognitive 
decline. Age, Vol.32, No.1, pp. 61-67.  
Sottas, P.; Saudan, C.; Schweizer, C.; Baume, N.; Mangin, P. & Saugy, M. (2008). From 
population- to subject-based limits of T/E ratio to detect testosterone abuse in elite 
sports. Forensic Science International, Vol.174, No.2-3, pp. 166-172.  
Stanczyk, F. Z.; Lee, J. S. & Santen, R. J. (2007). Standardization of steroid hormone assays: 
Why, how, and when? Cancer Epidemiology Biomarkers and Prevention, Vol.16, No.9, 
pp. 1713-1719.  
Stephany, R. (2001). Hormones in meat: Different approaches in the EU and in the USA. Acta 
Pathologica, Microbiologica et Immunologica Scandinavica, Vol.109, pp. S357-S363 
Stolker, A.; Groot, M.; Lasaroms, J.; Nijrolder, A.; Blokland, M. & Riedmaier, I. (2009). 
Detectability of testosterone esters and estradiol benzoate in bovine hair and 
plasma following pour-on treatment. Analytical and Bioanalytical Chemistry, Vol.395, 
No.4, pp. 1075-1087.  
www.intechopen.com
 
Natural Hormones in Food-Producing Animals: Legal Measurementsand Analytical Implications 
 
229 
Stolker, A. A. M.; Rutgers, P.; Oosterink, E.; Lasaroms, J. J. P.; Peters, R. J. B.; Van Rhijn, J. A. 
& Nielen, M.W.F. (2008). Comprehensive screening and quantification of veterinary 
drugs in milk using UPLC-ToF-MS. Analytical and Bioanalytical Chemistry, Vol.391, 
No.6, pp. 2309-2322.  
Strahm, E.; Baume, N.; Mangin, P.; Saugy, M.; Ayotte, C. & Saudan, C. (2009). Profiling of 
19-norandrosterone sulfate and glucuronide in human urine: Implications in 
athlete's drug testing. Steroids, Vol.74, No.3, pp. 359-364.  
Strous, R. D.; Maayan, R.; Lapidus, R.; Goredetsky, L.; Zeldich, E.; Kotler, M. & Weizman, A. 
(2004). Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone 
sulphate in first-episode schizophrenia: Relationship to gender, aggression and 
symptomatology. Schizophrenia Research, Vol.71, No.2-3, pp. 427-434.  
Swan, S. H.; Liu, F.; Overstreet, J. W.; Brazil, C. & Skakkebaek, N. E. (2007). Semen quality of 
fertile US males in relation to their mothers' beef consumption during pregnancy. 
Human Reproduction, Vol.22, No.6, pp. 1497-1502.  
Torrado, S.; Roig, M.; Farré, M.; Segura, J. & Ventura, R. (2008). Urinary metabolic profile of 
19-norsteroids in humans: Glucuronide and sulphate conjugates after oral 
administration of 19-nor-4-androstenediol. Rapid Communications in Mass 
Spectrometry, Vol.22, No.19, pp. 3035-3042.  
U.S. Department of Health and Human Services (FDA) (2006). Guidance for industry: 
General principles for evaluating the safety of compounds used in food-producing 
animals.  
U.S. FDA (2010). Animal drugs @ FDA. 13/07/2010, Available from 
http://www.accessdata.fda.gov/scripts/animaldrugsatfda/index.cfm  
USDA (2009). Beef 2007–08, part III: Changes in the U.S. beef cow-calf industry, 1993–2008. 
In: USDA:APHIS:VS, CEAH. Fort Collins, CO(#N512-1008)  
Vallejo, M.; Garcia, A.; Tunon, J.; García-Martínez, D.; Angulo, S.; Martín-Ventura, J. L.; 
Blanco-Colio, L.M.; Almeida, P.; Egido, J. & Barbas, C.  (2009). Plasma 
fingerprinting with GC-MS in acute coronary syndrome. Analytical and Bioanalytical 
Chemistry, Vol.394, No.6, pp. 1517-1524.  
Vanhaecke, L.; Bussche, J. V.; Wille, K.; Bekaert, K. & De Brabander, H. F. (2011). Ultra-high 
performance liquid chromatography–tandem mass spectrometry in high-
throughput confirmation and quantification of 34 anabolic steroids in bovine 
muscle. Analytica Chimica Acta, Vol.700, No.1-2, pp. 70-77.  
Vilariño, M.; Rubianes, E.; van Lier, E. & Menchaca, A. (2010). Serum progesterone 
concentrations, follicular development and time of ovulation using a new 
progesterone releasing device (DICO®) in sheep. Small Ruminant Research, Vol.91, 
No.2-3, pp. 219-224.  
Wang, Y.; Tang, H.; Nicholson, J. K.; Hylands, P. J.; Sampson, J. & Holmes, E. (2005). A 
metabolic strategy for the detection of the metabolic effects of chamomile 
(matricaria recutita L.) ingestion. Journal of Agricultural and Food Chemistry, Vol.53, 
pp. 191-196.  
Werner, E.; Croixmarie, V.; Umbdenstock, T.; Ezan, E.; Chaminade, P.; Tabet, J. C. & Junot, 
C. (2008). Mass spectrometry-based metabolomics: Accelerating the 
characterization of discriminating signals by combining statistical correlations and 
ultrahigh resolution. Analytical Chemistry, Vol.80, No.13, pp. 4918-4932.  
www.intechopen.com
 
Food Production – Approaches, Challenges and Tasks 
 
230 
Wigle, D. T.; Turner, M. C.; Gomes, J. & Parent, M. (2008). Role of hormonal and other 
factors in human prostate cancer. Journal of Toxicology and Environmental Health - 
Part B: Critical Reviews, Vol.11, No.3-4, pp. 242-259.  
Wiley, A. S. (2011). Milk intake and total dairy consumption: Associations with early 
menarche in NHANES 1999-2004. PLoS ONE, Vol.6, No.2, pp. e14685.  
Xu, C. L.; Chu, X. G.; Peng, C. F.; Jin, Z. Y. & Wang, L. Y. (2006). Development of a faster 
determination of 10 anabolic steroids residues in animal muscle tissues by liquid 
chromatography tandem mass spectrometry. Journal of Pharmaceutical and 
Biomedical Analysis, Vol.41, No.l2, pp. 616-621.  
Yager, J. D. & Davidson, N. E. (2006). Estrogen carcinogenesis in breast cancer. New England 
Journal of Medicine, Vol.354, No.3, pp. 270-282. 
Yang, Y.; Shao, B.; Zhang, J.; Wu, Y. & Duan, H. (2009). Determination of the residues of 50 
anabolic hormones in muscle, milk and liver by very-high-pressure liquid 
chromatography–electrospray ionization tandem mass spectrometry. Journal of 
Chromatography B, Vol.877, pp. 489-496.  
Zhong, S.; Ye, W.; Feng, E.; Lin, S.; Liu, J.; Leong, J.; Ma, C. & Lin, Y.C. (2011). Serum derived 
from zeranol-implanted ACI rats promotes the growth of human breast cancer cells 
in vitro. Anticancer Research, Vol.31, No.2, pp. 481-486.  
www.intechopen.com
Food Production - Approaches, Challenges and Tasks
Edited by Prof. Anna Aladjadjiyan
ISBN 978-953-307-887-8
Hard cover, 270 pages
Publisher InTech
Published online 20, January, 2012
Published in print edition January, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
This book is devoted to food production and the problems associated with the satisfaction of food needs in
different parts of the world. The emerging food crisis calls for development of sustainable food production, and
the quality and safety of the food produced should be guaranteed. The book contains thirteen chapters and is
divided into two sections. The first section is related to social issues rising from food insufficiency in the third
world countries, and is titled "Sustainable food production: Case studies". The case studies of semi-arid Africa,
Caribbean and Jamaica, Burkina Faso, Nigeria, Pacific Islands, Mexico and Brazil are discussed. The second
section, titled "Scientific Methods for Improving Food Quality and Safety", covers the methods for control and
avoidance of food contaminants. Substitution of chemical treatment with physical, rapid analytical methods for
control of contaminants, problems in animal husbandry related to diary production and hormones in food
producing animals, approaches and tasks in maize and rice production are in the covered by 6 chapters in this
section.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
atricia Regal, Alberto Cepeda and Cristina A. Fente (2012). Natural Hormones in Food-Producing
Animals:Legal Measurements and Analytical Implications, Food Production - Approaches, Challenges and
Tasks, Prof. Anna Aladjadjiyan (Ed.), ISBN: 978-953-307-887-8, InTech, Available from:
http://www.intechopen.com/books/food-production-approaches-challenges-and-tasks/natural-hormones-in-
food-producing-animals-legal-measurements-and-analytical-implications
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
